Retrospective analysis of pts treated with cetuximab or panitumumab at an Italian and a Swiss cancer center.Primary or secondary endpoints were not defined.PCR amplification with specific primers followed by automated sequencing by ABI PRISM 3730 was used to identify KRAS and BRAF sequence variants. Here, KRAS is linked to cancer.